Plasma endothelin-1

Clinical significance in cardiovascular diseases

A. Morganti

Research output: Contribution to journalArticle

Abstract

There is increasing evidence from in vitro and animal studies that endothelin-1 (ET-1) plays a relevant role in a number of pathophysiological conditions; yet such a role is usually attributed to the locally generated ET-1 rather than to the circulating peptide. However there are several cardiovascular diseases in which plasma levels of ET-1 may reach concentrations high enough to function as classical hormones. In these conditions which include common disorders such as myocardial infarction, congestive heart failure and pulmonary hypertension, the measurement of plasma ET-1 may be clinically useful both for prognostic and therapeutic purposes.

Original languageEnglish
JournalJournal of Hypertension, Supplement
Volume16
Issue number8
Publication statusPublished - 1998

Fingerprint

Endothelin-1
Cardiovascular Diseases
Pulmonary Hypertension
Heart Failure
Myocardial Infarction
Hormones
Peptides
Therapeutics

Keywords

  • Atherosclerosis
  • Endothelin-1
  • Heart failure
  • Hypertension
  • Pulmonary hypertension

ASJC Scopus subject areas

  • Internal Medicine

Cite this

Plasma endothelin-1 : Clinical significance in cardiovascular diseases. / Morganti, A.

In: Journal of Hypertension, Supplement, Vol. 16, No. 8, 1998.

Research output: Contribution to journalArticle

@article{ed9b5d43c8ab44ba9e5577276ea61ca1,
title = "Plasma endothelin-1: Clinical significance in cardiovascular diseases",
abstract = "There is increasing evidence from in vitro and animal studies that endothelin-1 (ET-1) plays a relevant role in a number of pathophysiological conditions; yet such a role is usually attributed to the locally generated ET-1 rather than to the circulating peptide. However there are several cardiovascular diseases in which plasma levels of ET-1 may reach concentrations high enough to function as classical hormones. In these conditions which include common disorders such as myocardial infarction, congestive heart failure and pulmonary hypertension, the measurement of plasma ET-1 may be clinically useful both for prognostic and therapeutic purposes.",
keywords = "Atherosclerosis, Endothelin-1, Heart failure, Hypertension, Pulmonary hypertension",
author = "A. Morganti",
year = "1998",
language = "English",
volume = "16",
journal = "Journal of Hypertension, Supplement",
issn = "0952-1178",
publisher = "Lippincott Williams and Wilkins",
number = "8",

}

TY - JOUR

T1 - Plasma endothelin-1

T2 - Clinical significance in cardiovascular diseases

AU - Morganti, A.

PY - 1998

Y1 - 1998

N2 - There is increasing evidence from in vitro and animal studies that endothelin-1 (ET-1) plays a relevant role in a number of pathophysiological conditions; yet such a role is usually attributed to the locally generated ET-1 rather than to the circulating peptide. However there are several cardiovascular diseases in which plasma levels of ET-1 may reach concentrations high enough to function as classical hormones. In these conditions which include common disorders such as myocardial infarction, congestive heart failure and pulmonary hypertension, the measurement of plasma ET-1 may be clinically useful both for prognostic and therapeutic purposes.

AB - There is increasing evidence from in vitro and animal studies that endothelin-1 (ET-1) plays a relevant role in a number of pathophysiological conditions; yet such a role is usually attributed to the locally generated ET-1 rather than to the circulating peptide. However there are several cardiovascular diseases in which plasma levels of ET-1 may reach concentrations high enough to function as classical hormones. In these conditions which include common disorders such as myocardial infarction, congestive heart failure and pulmonary hypertension, the measurement of plasma ET-1 may be clinically useful both for prognostic and therapeutic purposes.

KW - Atherosclerosis

KW - Endothelin-1

KW - Heart failure

KW - Hypertension

KW - Pulmonary hypertension

UR - http://www.scopus.com/inward/record.url?scp=0032460203&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032460203&partnerID=8YFLogxK

M3 - Article

VL - 16

JO - Journal of Hypertension, Supplement

JF - Journal of Hypertension, Supplement

SN - 0952-1178

IS - 8

ER -